相关实验视频
Updated: Feb 27, 2026

06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
12.6K
脂蛋白和心血管疾病:从遗传风险因素到治疗目标
Hyeong Rok Yun1,2, Manish Kumar Singh1,2, Sunhee Han2,3
1Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Cells
|February 26, 2026
概括
脂蛋白 (Lp) 是心血管疾病的关键遗传风险因素. 新兴疗法现在针对Lp(a),将其从不可治疗的生物标志物转变为可治疗的目标,以更好地预防心血管疾病.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脂蛋白[Lp[a]是动脉样硬化心血管疾病 (ASCVD) 和动脉狭窄症 (CAVS) 的重要,基因决定的风险因素.
- 升高的Lp (a) 影响全球大约20%的人口,但缺乏有效的药理疗法,造成了残留心血管风险管理的差距.
研究的目的:
- 综合目前关于Lp (a) 结构,遗传学和新陈代谢的知识.
- 审查Lp(a) 和心血管疾病途径之间的机制联系.
- 提供新兴的Lp(a) 向疗法及其对精确心血管预防的影响的概述.
主要方法:
- 文献综述综合了关于Lp (a) 分子结构,遗传学和新陈代谢的数据.
- 整合机理学证据,将Lp(a) 与亲动脉瘤,亲炎症和亲血栓性通路联系起来.
- 流行病学和遗传学数据的摘要,将Lp(a) 与心血管结果联系起来.
- 目前临床指南的概述Lp(a) 查和风险分层.
- 审查新兴的治疗策略,包括RNA向疗法和小分子.
主要成果:
- 在机理上,Lp (a) 与驱动动动脉硬化,炎症和血栓形成的关键途径有关.
- 流行病学和遗传学数据强烈地将升高的Lp (a) 与各种心血管结果联系起来.
- 新一波的疗法,包括向RNA和小分子药物,正处于后期发展阶段,以向Lp.
结论:
- 该领域正朝着将Lp(a) 视为可操作的治疗标,而不仅仅是生物标记物的方向发展.
- 新兴疗法有望改善ASCVD和CAVS的残留风险管理.
- 针对Lp (a) 代表了精确心血管预防策略的重大进步.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Atherosclerosis III: Management
512
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
512
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis I: Introduction
1.6K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
698
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
698
Coronary Artery Disease IV: Preventive Measures
770
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
770

